Dong-A ST challenges ‘Viread’ with ‘Virreal,’ hepatitis B treatment

Dong-A ST will challenge ‘Viread’ by launching ‘Virreal Tab,’ a hepatitis B treatment, on the 1^st of October.

Virreal Tab is a product which changed fumarate from tenofovir disoproxil fumarate, the main substance of ‘Viread Tab, ‘a hepatitis B treatment, to orotates, and acquired approval from the Ministry of Food and Drug Safety in Korea on August this year.

In various research results, one ...